Work

Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia

Year: 2009

Type: review

Source: Drug Discovery Today

DOI: 10.1016/j.drudis.2009.05.002

Authors: John H. Krystal, David F. Tolin, Gerard Sanacora, Stacy A. Castner, Graham V. Williams, Deane E. Aikins, Ralph E. Hoffman, D. Cyril D'Souza

Institutions: Yale University, VA Connecticut Healthcare System, Connecticut Mental Health Center, Hartford Hospital, Yale New Haven Hospital

Language: English

Topic: Neuroscience and Neuropharmacology Research

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, National Institute of Mental Health, National Institute on Drug Abuse

Awards: G1428252806, CORTICAL GABA FUNCTION IN ALCOHOLISM, G3001689072, Calcium Signaling & Prefrontal Deficits in Schizophrenia, The Interactive Impact of Cocaine and Schizophrenia on Prefrontal Function, Studies of Amino Acid Neurotransmitter Contributions to Depression, AMINO ACID NEUROTRANSMITTER DYSREGULATION IN ALCOHOLISM, CORTICAL MECHANISMS IN SCHIZOPHRENIA, Center for the Translational Neuroscience of Alcoholism

OpenAlex ID: W2047894110

FWCI: 0.509

Cites: 131

Cited by: 77

Related to: 10